Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study (Q44799322)
Jump to navigation
Jump to search
scientific article published on 7 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study |
scientific article published on 7 January 2015 |
Statements
1 reference
Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study (English)
1 reference
1 reference
Walter Reinisch
1 reference
Sunil Khurana
1 reference
Gabor Toth
1 reference
Fei Hua
1 reference
Gail M Comer
1 reference
Michelle Hinz
1 reference
Karen Page
1 reference
Margot O'Toole
1 reference
Tara McDonnell Moorehead
1 reference
Hua Zhu
1 reference
YanHui Sun
1 reference
Fabio Cataldi
1 reference
7 January 2015
1 reference
1 reference
64
1 reference
6
1 reference
894-900
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference